LONG-TERM EFFECTS OF FLUOXETINE ON GLYCEMIC CONTROL IN OBESE PATIENTSWITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS OR GLUCOSE-INTOLERANCE -INFLUENCE ON MUSCLE GLYCOGEN-SYNTHASE AND INSULIN-RECEPTOR KINASE-ACTIVITY
L. Breum et al., LONG-TERM EFFECTS OF FLUOXETINE ON GLYCEMIC CONTROL IN OBESE PATIENTSWITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS OR GLUCOSE-INTOLERANCE -INFLUENCE ON MUSCLE GLYCOGEN-SYNTHASE AND INSULIN-RECEPTOR KINASE-ACTIVITY, Metabolism, clinical and experimental, 44(12), 1995, pp. 1570-1576
Fluoxetine (F) is a specific serotonin-reuptake inhibitor that has bee
n shown to promote weight loss and improve glycemic control in obese d
iabetic patients. To study its long-term metabolic effect, 40 obese pa
tients with non-insulin-dependent diabetes mellitus (NIDDM) or impaire
d glucose tolerance (IGT) were included in a 19-month, randomized, pla
cebo-controlled study. Patients were assigned to receive either 60 mg
F or placebo (P) daily in conjunction with a 5.0-MJ/d diet (> 50% carb
ohydrate). Both groups showed a significant weight loss, with a nadir
after 6 months without group differences (mean +/- SD: F, 10.1 +/- 10.
0 kg; P, 9.4 +/- 11.5 kg). Fifteen patients from the F group and 14 fr
om the P group completed the 12-month study without weight loss differ
ences. Glycemic regulation improved along with the weight loss, but wi
th a larger decline in plasma C-peptide and fasting glucose levels in
the F group (P <.05). Total skeletal muscle glycogen synthase (GS) act
ivity increased by 31% in the F group (P <.01) and by 17% in the P gro
up (nonsignificant) after 6 months of treatment, but was still less th
an the activity in normal-weight controls (aged 28.0 +/- 6.3 years; bo
dy mass index, 23.5 +/- 2.2). After adjustment for fasting glucose, in
sulin, weight loss, and diabetic state, a positive effect of F remaine
d on the total GS activity, which accounted for 27% of the variation (
P <.05). The waist to hip ratio was reduced in P subjects as compared
with F subjects (P <.05). Fat-free mass (FFM) tended to be more reduce
d in the F group as compared with P subjects (4.9 v 1.9 kg), although
the difference did not reach statistical significance. In conclusion,
F seems to improve insulin sensitivity beyond the effect mediated thro
ugh weight loss by a possible effect on GS activity in skeletal muscle
tissue. Copyright (C) 1995 by W.B. Saunders Company